LivaNova is a medical device company in the treatment of cardiovascular diseases. The company develops, manufactures, and markets medical technologies for cardiac surgery and for the treatment of cardiac rhythm disorders.
20 Eastbourne Terrace
London, W2 6LG
England, United Kingdom
|2021-01-11||Noctrix Health||Series B||$17M||OrbiMed Advisors, and Treo Venture|
|2019-10-25||ShiraTronics||Series A||$33M||Amzak Capital Management, Aperture Venture Partners, Synergy Life Science Partners, Treo Venture, U.S. Venture Partners, and Undisclosed Investors|
|2018-09-25||Ceribell||Series B||$35M||Optimas Capital, The Rise Fund, and UCB|